---
title: "12 Health Care Stocks Moving In Wednesday's Pre-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/297042717.md"
description: "During Wednesday's pre-market session, several healthcare stocks showed significant movement. Gainers included Nuwellis (up 27.2%), Summit Therapeutics (up 12.16%), and VolitionRX (up 11.62%). Conversely, losers featured OSR Health (down 21.7%), Biodexa Pharmaceuticals (down 12.72%), and Akanda (down 11.72%). The report highlights specific percentage changes and market capitalizations for these companies."
datetime: "2026-08-26T12:06:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/297042717.md)
  - [en](https://longbridge.com/en/news/297042717.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/297042717.md)
generator: "portal-rs"
---

# 12 Health Care Stocks Moving In Wednesday's Pre-Market Session

### Gainers

-   **Nuwellis** (NASDAQ:NUWE) stock increased by 27.2% to $1.22 during Wednesday's pre-market session. The market value of their outstanding shares is at $3.0 million.
-   **Summit Therapeutics** (NASDAQ:SMMT) stock rose 12.16% to $14.99. The company's market cap stands at $10.6 billion.
-   **VolitionRX** (AMEX:VNRX) shares moved upwards by 11.62% to $0.43. The market value of their outstanding shares is at $5.2 million.
-   **Celularity** (NASDAQ:CELU) shares moved upwards by 9.86% to $0.88. The market value of their outstanding shares is at $22.8 million.
-   **Evommune** (NYSE:EVMN) stock rose 9.49% to $15.1. The market value of their outstanding shares is at $500.4 million.
-   **TherapeuticsMD** (NASDAQ:TXMD) shares rose 9.21% to $2.49. The company's market cap stands at $26.3 million.

### Losers

-   **OSR Health** (NASDAQ:OSRH) shares declined by 21.7% to $0.09 during Wednesday's pre-market session. The company's market cap stands at $4.0 million.
-   **Biodexa Pharmaceuticals** (NASDAQ:BDRX) stock declined by 12.72% to $1.03. The market value of their outstanding shares is at $1.2 million.
-   **Akanda** (NASDAQ:AKAN) shares declined by 11.72% to $4.37. The market value of their outstanding shares is at $2.6 million.
-   **Spyre Therapeutics** (NASDAQ:SYRE) stock decreased by 10.59% to $96.0. The company's market cap stands at $9.2 billion.
-   **Autonomix Medical** (NASDAQ:AMIX) stock decreased by 9.18% to $6.53. The market value of their outstanding shares is at $6.9 million.
-   **Jupiter Neurosciences** (NASDAQ:JUNS) shares decreased by 9.1% to $4.7. The company's market cap stands at $6.8 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [OSRHW.US](https://longbridge.com/en/quote/OSRHW.US.md)
- [AKAN.US](https://longbridge.com/en/quote/AKAN.US.md)
- [NUWE.US](https://longbridge.com/en/quote/NUWE.US.md)
- [BDRX.US](https://longbridge.com/en/quote/BDRX.US.md)
- [VNRX.US](https://longbridge.com/en/quote/VNRX.US.md)
- [OSRH.US](https://longbridge.com/en/quote/OSRH.US.md)
- [SMMT.US](https://longbridge.com/en/quote/SMMT.US.md)
- [CELU.US](https://longbridge.com/en/quote/CELU.US.md)
- [EVMN.US](https://longbridge.com/en/quote/EVMN.US.md)
- [TXMD.US](https://longbridge.com/en/quote/TXMD.US.md)
- [SYRE.US](https://longbridge.com/en/quote/SYRE.US.md)
- [AMIX.US](https://longbridge.com/en/quote/AMIX.US.md)
- [JUNS.US](https://longbridge.com/en/quote/JUNS.US.md)
- [CELUW.US](https://longbridge.com/en/quote/CELUW.US.md)

## Related News & Research

- [Volition Presents Early Stage I Solid Cancer Detection at the ESMO MAP Conference | VNRX Stock News](https://longbridge.com/en/news/298594142.md)
- [VolitionRx prepays in full USD 7.5 million senior secured convertible note due 2027](https://longbridge.com/en/news/298916804.md)
- [Summit Therapeutics cites positive HARMONi-2 OS data: ivonescimab cuts death risk 27%, median OS +8.2 months](https://longbridge.com/en/news/298920431.md)
- [VolitionRx presents early stage I solid cancer detection data for Capture-Seq at ESMO MAP conference](https://longbridge.com/en/news/298592775.md)
- [VolitionRx highlights $5 million feline paper milestone in corporate deck](https://longbridge.com/en/news/298584532.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**